| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000031810 |
| Receipt No. | R000036325 |
| Official scientific title of the study | Influence of social determinants of health in patients with advanced lung cancer: a prospective cohort study |
| Date of disclosure of the study information | 2018/03/20 |
| Last modified on | 2018/09/19 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Influence of social determinants of health in patients with advanced lung cancer: a prospective cohort study | |
| Title of the study (Brief title) | Influence of social determinants of health in patients with advanced lung cancer | |
| Region |
|
|
| Condition | |||
| Condition | advanced lung cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | to assess the effects of SDH on patients with advanced lung cancer in Japan |
| Basic objectives2 | Others |
| Basic objectives -Others | To explore the relationship between exposures and outcomes |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | initial treatment |
| Key secondary outcomes | rout to diagnosis, overall survival, stage of cancer progression and performance status at the time of enrolment, and place of death |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. A pathological or clinical diagnosis of lung cancer
2. Willingness to provide written informed consent for enrolment in the study 3. Unsuitability for curative surgery 4. Previously untreated or within 2 months of starting treatment for newly diagnosed lung cancer. |
|||
| Key exclusion criteria | 1. Inability to complete a study questionnaire because of dementia or mental illness
2. Unsuitable for participation in the study in the opinion of the attending physician. |
|||
| Target sample size | 300 | |||
| Research contact person | |
| Name of lead principal investigator | Yuki Kataoka |
| Organization | Hyogo Prefectural Amagasaki General Medical Center |
| Division name | Department of Respiratory Medicine |
| Address | 2-17-77, Higashi Naniwacho, Amagasaki, Hyogo |
| TEL | 06-6480-7000 |
| hanshin.crt@gmail.com | |
| Public contact | |
| Name of contact person | Yuki Kataoka |
| Organization | Hyogo Prefectural Amagasaki General Medical Center |
| Division name | Department of Respiratory Medicine |
| Address | 2-17-77, Higashi Naniwacho, Amagasaki, Hyogo |
| TEL | 06-6480-7000 |
| Homepage URL | |
| hanshin.crt@gmail.com | |
| Sponsor | |
| Institute | Hyogo Prefectural Amagasaki General Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hyogo Prefectural Amagasaki General Medical Center |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 兵庫県立尼崎総合医療センター |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | The variables evaluated in this study will be social isolation, loneliness, employment, social security income, education, dementia, smoking history, weight loss, respiratory symptoms, tissue type, mutation status (epidermal growth factor receptor, anaplastic lymphoma kinase, ROS1), and programmed death-ligand 1 status.
Social isolation will be surveyed using the Japanese short version of the Lubben Social Network Scale (LSNS-6).Loneliness will be surveyed using the Japanese Version 3 of the UCLA (University of California, Los Angeles) Loneliness Scale. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000036325 |